Fiducient Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Fiducient Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-730	Closed	-$423K	–	168
2025 Q4	$423K	Buy	+730	New	+$413K	0.05%	118
2025 Q3	–	Sell	-707	Closed	-$287K	–	170
2025 Q2	$287K	Hold	707	–	–	0.04%	127
2025 Q1	$352K	Sell	707 -3	-0.4%	-$1.63K	0.04%	116
2024 Q4	$370K	Sell	710 -7	-1%	-$3.85K	0.05%	109
2024 Q3	$444K	Buy	717 +16	+2%	+$9.47K	0.05%	93
2024 Q2	$388K	Sell	701 -1,374	-66%	-$787K	0.05%	102
2024 Q1	$1.21M	Sell	2,075 -13	-0.6%	-$7.29K	0.24%	40
2023 Q4	$1.11M	Sell	2,088 -5	-0.2%	-$2.42K	0.21%	38
2023 Q3	$1.06M	Buy	+2,093	New	+$1.12M	0.06%	40
2021 Q2	–	Sell	-1,833	Closed	-$837K	–	87
2021 Q1	$837K	Buy	1,833 +33	+2%	+$15.8K	0.27%	32
2020 Q4	$838K	Buy	+1,800	New	+$844K	0.31%	28

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fiducient Advisors's TMO Position: Q1 2026 in Review

Fiducient Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 730 shares — an estimated $423K sold.

Fiducient Advisors first reported a position in TMO in Q4 2020 and held it in 11 quarters. The position peaked at $1.21M in Q1 2024. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Fiducient Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Fiducient Advisors sold 730 Thermo Fisher Scientific shares in Q1 2026, an estimated $423K.
Fiducient Advisors first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 11 quarters.
Fiducient Advisors's Thermo Fisher Scientific position peaked at $1.21M in Q1 2024.
2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Fiducient Advisors's 13F filing for Q1 2026, filed 11 May 2026.